TIM

USPTO Trademark Record

REGISTERED

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

Q: Who owns the TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX trademark?

The TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX trademark is owned by OSRX, Inc..

Q: What class is the TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX trademark registered in?

The TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

Q: What is the serial number for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX?

The USPTO serial number for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX is 88423694.

SN 88423694·Reg 6342255·Filed May 09, 2019

Owner OSRX, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX (Serial No. 88423694), Registration No. 6342255, is a registered US trademark filed on May 09, 2019 by OSRX, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Renewal window: May 04, 2027206 days remaining

Mark Intelligence

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX (Reg. #6342255) is a registered US trademark that has been protecting its owner, OSRX, Inc., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 09, 2019

SERIAL

88423694

REG#

6342255

REGISTERED

May 04, 2021

Owner

Applicant

OSRX, Inc.

Entity

Corporation

State

Address

1120 Kensington Ave., Suite E, Missoula, MT, 59801

Country

Attorney

NameBrendan J. Hughes

Law firm

Brendan J. Hughes Cooley LLP

Docket

348359

Address

1299 Pennsylvania Avenue, NW, Suite 700, Washington, DC 20004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 09, 2019

Serial Number88423694

Registration No.6342255

Registration DateMay 04, 2021

Status DateMay 04, 2021

Published for OppositionMar 03, 2020

Mark TypeDesign with words

Attorney Docket348359

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: May 01, 2019

First use in commerce: May 01, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

41 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 04, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 21, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 21, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 21, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Mar 10, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

Mar 10, 2025

WITHDRAWAL OF ATTORNEY GRANTED

REGISTERED-PRINCIPAL REGISTER

May 04, 2021

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 30, 2021

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 29, 2021

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 26, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 26, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

SU - NON-FINAL ACTION - WRITTEN

Oct 06, 2020

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Oct 06, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 06, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 02, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Oct 02, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 17, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 17, 2020

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 28, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 02, 2020

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 02, 2020

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 02, 2020

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 02, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 02, 2020

TEAS CHANGE OF OWNER ADDRESS RECEIVED

PUBLISHED FOR OPPOSITION

Mar 03, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 03, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 12, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Jan 29, 2020

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 29, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 24, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 23, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 22, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 22, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jul 25, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 25, 2019

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 25, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jul 24, 2019

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 25, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 24, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 13, 2019

NEW APPLICATION ENTERED

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by OSRX, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Brendan J. Hughes

Resources

Company